Oncology News

Dr. Susan Love-surgeon, researcher, advocate, author, and cancer survivor-will share insights learned during her recent battle with leukemia with Dr. Deborah Axelrod, Kanas Family Foundation Associate Professor of Surgical Oncology and Medical Director for Community Outreach & Education for the NYULMC Cancer Center, during a special discussion, ... (more)

On April 9, it released the latest evidence - research showing that a novel technique improves outcomes for women with breast cancer, the nation's No.

Doctors, God's healers and true soldiers of effort, are not to be stoned in our public squares, believes Tom Finneran.

By AzerNews People who are afraid of oncological diseases due to genetic factors will be able to learn about the probability of the disease in advance in Azerbaijan.

The prices of some cancer drugs are so high that they preclude researchers from conducting trials comparing their effectiveness, according to two National Cancer Institute researchers.

SCI Corporation , a late-stage oncology company, today announced that it has closed an underwritten public offering of units consisting of an aggregate of 7,128,229 shares of common stock and warrants to purchase an aggregate of 1,782,057 shares of common stock.

Two years ago doctors told Lisa Ridgeway she had triple negative breast cancer, a very aggressive disease with no cure.

XBiotech is announcing that results from its Phase I/II oncology study conducted at MD Anderson Cancer Center in Houston, TX were published today in Lancet Oncology.

A time-of-flight mass cytometer is the centerpiece of the new Center for Human Immunology and Immunotherapy Programs, a center that helps scientists use the immune system to fight cancer and infection.

Roche Holdings recently released its Q1 2014 results and reported a slight decline of 1% in its revenues.

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration and European Commission have granted Orphan Drug Designation to volasertib for acute myeloid leukemia .

Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration and European Commission have granted Orphan Drug Designation to volasertib for ... (more)

Valerie Harper faced a dismal future when her doctors announced point blank that she had terminal brain cancer.

Children at St. Antoine French Catholic school in Tecumseh carried or rolled in box after box of art and craft supplies Wednesday in memory of former fellow student Daniel Ethier.

Because any single gene mutation behind a particular cancer can be extremely rare, studying one drug at a time is extremely challenging Scientists and drug makers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market.

Researchers report early progress in developing a treatment that might one day help the immune system defend itself against cancer.

Valerie Harper has gained ground in her battle with brain cancer. "I'm absolutely cancer-free!" she told Closer magazine .

Veteran actress Valerie Harper has declared herself cancer-free, just over a year after doctors warned her she had months to live.

Staff at law firm Mourant Ozannes had a 'hairy' experience for charity last week, raising essential funds to help cancer patients.

BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company PARIS & COPENHAGEN, Denmark-- --April 16, 2014-- Regulatory News: BioAlliance Pharma SA , an innovative company specialized in the development of drugs within orphan oncology diseases, and Topotarget A/S a Scandinavian-based biopharmaceutical ... (more)